TRAILRUNNER-ALZ 3 is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine may help treat people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)